Home
Screener
GRTS
profile

GRTS Company Profile and Key Details

NASDAQ : GRTS

Gritstone bio, Inc.

$0.03

-0.015-31.78%

At Close 4:00 PM

Not Actively Trading

69.87

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

GRTS Stock Price Chart

Stock Price Today

Gritstone bio, Inc. (GRTS) stock declined over -31.78%, trading at $0.03 on NASDAQ, down from the previous close of $0.05. The stock opened at $0.04, fluctuating between $0.03 and $0.04 in the recent session.

Stock Snapshot

0.0472

Prev. Close

0.04

Open

3.8M

Market Cap

118.11M

Number of Shares

0.031

Day Low

0.0403

Day High

-0.029541284403669724

P/E Ratio

97.74%

Free Float in %

-1.09

EPS (TTM)

0.53

Book Value

-1.45

Cash Flow per Share

55.25M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Nov 15, 2024	0.02	0.03	0.02	0.02	714.55K
Nov 14, 2024	0.03	0.03	0.02	0.03	1.65M
Nov 12, 2024	0.03	0.03	0.03	0.03	1.51M
Nov 11, 2024	0.02	0.03	0.02	0.03	1.88M
Nov 07, 2024	0.02	0.03	0.02	0.03	2.11M
Nov 06, 2024	0.03	0.03	0.02	0.03	1.55M
Nov 05, 2024	0.03	0.03	0.02	0.02	1.59M
Nov 04, 2024	0.03	0.03	0.03	0.03	911.84K
Nov 01, 2024	0.03	0.03	0.02	0.03	3.74M
Oct 30, 2024	0.02	0.02	0.02	0.02	1.13M
Oct 29, 2024	0.02	0.02	0.02	0.02	2.32M
Oct 25, 2024	0.02	0.03	0.02	0.02	4.17M
Oct 22, 2024	0.01	0.03	0.01	0.02	18.42M
Oct 21, 2024	0.04	0.04	0.03	0.03	55.25M
Oct 18, 2024	0.05	0.05	0.05	0.05	33.86M
Oct 17, 2024	0.05	0.06	0.05	0.05	48.61M
Oct 16, 2024	0.07	0.07	0.06	0.06	60.81M
Oct 15, 2024	0.08	0.08	0.06	0.07	355.1M
Oct 14, 2024	0.05	0.08	0.05	0.05	162.33M
Oct 11, 2024	0.06	0.06	0.05	0.05	63.23M

Contact Details

EmeryVille, CA 94608

United States

Website: https://gritstonebio.comContact: 510 871 6100

About Company

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate for the treatment of common solid tumors comprising metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and shared neoantigen-positive tumors. In addition, it develops CORAL, a SARS-CoV-2 vaccine platform designed to deliver spike and additional SARS-CoV-2 T cell epitopes for protection and broader immunity against SARS-CoV-2 variants; and a therapeutic vaccine candidate designed to treat and cure human immunodeficiency virus (HIV) infection. It has a strategic collaboration with bluebird bio, Inc.; collaboration agreement with Gilead Sciences, Inc.; and license agreement with Genevant Sciences GmbH. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.

Frequently Asked Questions

What is the current Gritstone bio, Inc. (GRTS) stock price?

Gritstone bio, Inc. (NASDAQ: GRTS) stock price is $0.03 in the last trading session. During the trading session, GRTS stock reached the peak price of $0.04 while $0.03 was the lowest point it dropped to. The percentage change in GRTS stock occurred in the recent session was -31.78% while the dollar amount for the price change in GRTS stock was -$0.02.

GRTS's industry and sector of operation?

The NASDAQ listed GRTS is part of Biotechnology industry that operates in the broader Healthcare sector. Gritstone bio, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of GRTS?

Mr. James Cho
Chief Accounting Officer
Dr. Matthew J. Hawryluk M.B.A., Ph.D.
Executive Vice President & Chief Bus. Officer
Mr. Vijay Yabannavar Ph.D.
Executive Vice President & Chief Technical Devel. Officer
Dr. Matthew Hawryluk
Executive Vice President & Chief Bus. Officer
George MacDougall
Director of Investor Relations & Corporation Communications
Dr. Andrew R. Allen BCh, BM, M.D., MA, MRCP, Ph.D.
Co-Founder, Pres, Chief Executive Officer & Director
Mr. Erin E. Jones M.S.
Executive Vice President & Chief Operating Officer
Dr. Karin Jooss Ph.D.
Executive Vice President and Head of R&D
Ms. Vassiliki Economides
Executive Vice President & Chief Financial Officer

How GRTS did perform over past 52-week?

GRTS's closing price is 7.33% higher than its 52-week low of $0.03 where as its distance from 52-week high of $3.17 is -98.98%.

How many employees does GRTS have?

Number of GRTS employees currently stands at 231.

Link for GRTS official website?

Official Website of GRTS is: https://gritstonebio.com

How do I contact GRTS?

GRTS could be contacted at phone 510 871 6100 and can also be accessed through its website. GRTS operates from 5959 Horton Street, EmeryVille, CA 94608, United States.

How many shares of GRTS are traded daily?

GRTS stock volume for the day was 55.25M shares. The average number of GRTS shares traded daily for last 3 months was 17.01M.

What is the market cap of GRTS currently?

The market value of GRTS currently stands at $3.80M with its latest stock price at $0.03 and 118.11M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

GRTS Stock Price Chart

Stock Price Today

Stock Snapshot

0.0472

Prev. Close

0.04

Open

3.8M

Market Cap

118.11M

Number of Shares

0.031

Day Low

0.0403

Day High

-0.029541284403669724

P/E Ratio

97.74%

Free Float in %

-1.09

EPS (TTM)

0.53

Book Value

-1.45

Cash Flow per Share

55.25M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Nov 15, 2024	0.02	0.03	0.02	0.02	714.55K
Nov 14, 2024	0.03	0.03	0.02	0.03	1.65M
Nov 12, 2024	0.03	0.03	0.03	0.03	1.51M
Nov 11, 2024	0.02	0.03	0.02	0.03	1.88M
Nov 07, 2024	0.02	0.03	0.02	0.03	2.11M
Nov 06, 2024	0.03	0.03	0.02	0.03	1.55M
Nov 05, 2024	0.03	0.03	0.02	0.02	1.59M
Nov 04, 2024	0.03	0.03	0.03	0.03	911.84K
Nov 01, 2024	0.03	0.03	0.02	0.03	3.74M
Oct 30, 2024	0.02	0.02	0.02	0.02	1.13M
Oct 29, 2024	0.02	0.02	0.02	0.02	2.32M
Oct 25, 2024	0.02	0.03	0.02	0.02	4.17M
Oct 22, 2024	0.01	0.03	0.01	0.02	18.42M
Oct 21, 2024	0.04	0.04	0.03	0.03	55.25M
Oct 18, 2024	0.05	0.05	0.05	0.05	33.86M
Oct 17, 2024	0.05	0.06	0.05	0.05	48.61M
Oct 16, 2024	0.07	0.07	0.06	0.06	60.81M
Oct 15, 2024	0.08	0.08	0.06	0.07	355.1M
Oct 14, 2024	0.05	0.08	0.05	0.05	162.33M
Oct 11, 2024	0.06	0.06	0.05	0.05	63.23M

Contact Details

EmeryVille, CA 94608

United States

Website: https://gritstonebio.comContact: 510 871 6100

About Company

Frequently Asked Questions

What is the current Gritstone bio, Inc. (GRTS) stock price?

GRTS's industry and sector of operation?

Who are the executives of GRTS?

How GRTS did perform over past 52-week?

GRTS's closing price is 7.33% higher than its 52-week low of $0.03 where as its distance from 52-week high of $3.17 is -98.98%.

How many employees does GRTS have?

Number of GRTS employees currently stands at 231.

Link for GRTS official website?

Official Website of GRTS is: https://gritstonebio.com

How do I contact GRTS?

GRTS could be contacted at phone 510 871 6100 and can also be accessed through its website. GRTS operates from 5959 Horton Street, EmeryVille, CA 94608, United States.

How many shares of GRTS are traded daily?

GRTS stock volume for the day was 55.25M shares. The average number of GRTS shares traded daily for last 3 months was 17.01M.

What is the market cap of GRTS currently?

The market value of GRTS currently stands at $3.80M with its latest stock price at $0.03 and 118.11M of its shares outstanding.

Employees	231
Beta	0.5
Sales or Revenue	$1.33M
5Y Sales Change%	-0.913%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	231
Beta	0.5
Sales or Revenue	$1.33M
5Y Sales Change%	-0.913%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

GRTS Company Profile and Key Details

Gritstone bio, Inc.

GRTS Stock Price Chart

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions

GRTS Stock Price Chart

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions